R1 RCM (RCM) Stock Price, News & Analysis

Company Overview

R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.

Key Stats

• Today's Range: $14.30 to $14.32
• 50-Day Range: $14.20 to $14.31
• 52-Week Range: $8.87 to $15.12
• Volume: 13.78 million shs
• Average Volume: 3.58 million shs
• Market Capitalization: $6.04 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $15.73
• Consensus Rating: Hold

R1 RCM Stock Analysis - MarketRank™

R1 RCM scored higher than 23% of companies evaluated by MarketBeat, and ranked 268th out of 326 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.1 / 5
• Analyst Rating: Hold

Consensus Rating

R1 RCM has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 5 buy ratings, 12 hold ratings, and no sell ratings.

Amount of Analyst Coverage

R1 RCM has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for R1 RCM are expected to grow in the coming year, from ($0.18) to $0.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of R1 RCM is -95.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of R1 RCM is -95.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

R1 RCM has a P/B Ratio of 2.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for RCM.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

R1 RCM does not currently pay a dividend.

Dividend Growth

R1 RCM does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.33

Short Interest

There is no current short interest data available for RCM.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, R1 RCM insiders have not sold or bought any company stock.

Percentage Held by Insiders

36.80% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

RCM Stock Analysis - Frequently Asked Questions

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) announced its earnings results on Tuesday, November, 5th. The healthcare provider reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.04. The business's revenue was up 14.7% compared to the same quarter last year.

Does R1 RCM have any subsidiaries?

R1 RCM subsidiaries include these companies: Cloudmed, VisitPay, Cerner RevWorks, SCI Solutions, Intermedix, Accretive Health Mauritius Inc., cGate Health Inc., and more.

Who are R1 RCM's major shareholders?

Top institutional investors of R1 RCM include Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC and HAP Trading LLC. Insiders that own company stock include Achi Series Lllp Tcp-Asc, Joseph Gerard Flanagan, John M Sparby, Richard B Jr Evans, John B Henneman III and Lee Rivas.
View institutional ownership trends.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some other companies that R1 RCM investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

• Last Earnings: 11/05/2024
• Today: 2/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Management services
• Sub-Industry: Health Care Services
• Current Symbol: NASDAQ:RCM
• Previous Symbol: NYSE:RCM
• CUSIP: 00438V10
• CIK: 1472595
• Web: www.r1rcm.com
• Phone: (312) 324-7820
• Fax: 302-655-5049
• Employees: 30,000
• Year Founded: 2003

Price Target and Rating

• Average Stock Price Target: $15.73
• High Stock Price Target: $19.00
• Low Stock Price Target: $14.00
• Potential Upside/Downside: +9.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.29
• Research Coverage: 17 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.15)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.30 million
• Net Margins: -2.48%
• Pretax Margin: -2.34%
• Return on Equity: -2.18%
• Return on Assets: -1.10%

Debt

• Debt-to-Equity Ratio: 0.76
• Current Ratio: 1.79
• Quick Ratio: 1.79

Sales & Book Value

• Annual Sales: $2.25 billion
• Price / Sales: 2.68
• Cash Flow: $0.69 per share
• Price / Cash Flow: 20.89
• Book Value: $6.66 per share
• Price / Book: 2.15

Miscellaneous

• Outstanding Shares: 422,390,000
• Free Float: 266,953,000
• Market Cap: $6.04 billion
• Optionable: Optionable
• Beta: 0.84